Biosynthetic and hybrid xenograft hernia matrices continue to drive growth in hernia matrices, but breast matrices decline slightly in Q123.
- Complete Q123 US Surgical Matrices Market Overview
- SmartTRAK's Expert Market Analysis and Insights
- All Company News, Revenues, Data, Charts and Shares
- US Surgical Matrices Market Shuffles Leadership
- US Breast Matrices: Holding Steady
- US Hernia Repair Matrices Market: Another Solid Quarter
- Q123 Clinical/Regulatory Highlights
The US Surgical Matrices Market grew in Q123 with more strength in the Hernia Matrices segment, due to the continued growth of biosynthetic matrices and TELA Bio’s OviTex as physicians use them for ...
Read the entire Q123 US Surgical Matrices Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares**These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
